DAI Dan, WANG Xinmiao, HE Chunyan, et al. Professor ZHANG Zuozhou's Experience in Treatment of Psoriasis from the Pathogenesis of Blood Stasis and Toxin[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13288/j.11-2166/r.2021.02.004
DOI:
DAI Dan, WANG Xinmiao, HE Chunyan, et al. Professor ZHANG Zuozhou's Experience in Treatment of Psoriasis from the Pathogenesis of Blood Stasis and Toxin[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13288/j.11-2166/r.2021.02.004DOI:
Professor ZHANG Zuozhou's Experience in Treatment of Psoriasis from the Pathogenesis of Blood Stasis and Toxin
The paper summarized professor ZHANG Zuozhou's experience in treating psoriasis from the pathogenesis of blood stasis and toxin. Professor ZHANG Zuozhou puts forward that "blood stasis and heat toxin accumulation" is the core pathogenesis of psoriasis, and the therapeutic methods are clearing heat, resolving toxins, invigorating blood circulation and dissolving stasis. Upholding the concept that "one recipe corresponds to one disease", he develops the self-made ,Jiedu Huoxue Decoction, (解毒活血汤) as basic recipe, and modifies it based on syndromes. He advocates the flexible use of herbs and emphasizes the precaution on insect medicine. In his opinion, the healthy ,qi, should be reinforced simultaneously when the pathogen is dispelled, and the spleen-stomach and ,yin,-fluids should be cared always. He also advocates to reform the herbal preparation type for external application, and suggests using cream instead of traditional paste.
关键词
银屑病瘀毒解毒活血汤名医经验张作舟
Keywords
psoriasisblood stasis and toxinJiedu Huoxue Decoction (解毒活血汤)experience of famous doctorsZHANG Zuozhou
JENSEN P, SKOV L. Psoriasis and obesity[J]. Dermatology, 2016, 232(6): 633-639.
LIANG SE, COHEN JM, HO RS. Screening for depression and suicidality in psoriasis patients: A survey of US dermatologists[J]. J Am Acad Dermatol, 2019, 80(5): 1460-1462.
DAUDEN E, CARRETERO G, RIVERA R, et al. Long term safety of nine systemic medications for psoriasis: a cohort study using the Biobadaderm Registry[J]. J Am Acad Dermatol, 2020, 83(1): 139-150.